Cargando…
1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506391/ http://dx.doi.org/10.1016/j.annonc.2020.08.1789 |
_version_ | 1783585007754805248 |
---|---|
author | Pastorino, A. Negru, M.E. Vigani, A. Vaira, F. Tognoni, A. Ferrari, A. Ricci, I. Rondini, M. Olcese, F. Milano, A. Cozzani, F. Aschele, C. |
author_facet | Pastorino, A. Negru, M.E. Vigani, A. Vaira, F. Tognoni, A. Ferrari, A. Ricci, I. Rondini, M. Olcese, F. Milano, A. Cozzani, F. Aschele, C. |
author_sort | Pastorino, A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7506391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75063912020-09-23 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak Pastorino, A. Negru, M.E. Vigani, A. Vaira, F. Tognoni, A. Ferrari, A. Ricci, I. Rondini, M. Olcese, F. Milano, A. Cozzani, F. Aschele, C. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506391/ http://dx.doi.org/10.1016/j.annonc.2020.08.1789 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Pastorino, A. Negru, M.E. Vigani, A. Vaira, F. Tognoni, A. Ferrari, A. Ricci, I. Rondini, M. Olcese, F. Milano, A. Cozzani, F. Aschele, C. 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak |
title | 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak |
title_full | 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak |
title_fullStr | 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak |
title_full_unstemmed | 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak |
title_short | 1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak |
title_sort | 1725p development and validation of telematic follow-up for cancer patients during the covid-19 outbreak |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506391/ http://dx.doi.org/10.1016/j.annonc.2020.08.1789 |
work_keys_str_mv | AT pastorinoa 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT negrume 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT vigania 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT vairaf 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT tognonia 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT ferraria 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT riccii 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT rondinim 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT olcesef 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT milanoa 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT cozzanif 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak AT aschelec 1725pdevelopmentandvalidationoftelematicfollowupforcancerpatientsduringthecovid19outbreak |